Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Flagship Pioneering, Inc | Institution | 12.674.120 | 21,59% | US$ 47,40M | 2026-03-31 |
| Flagship Ventures Fund V, L.P. | Institution | 9.330.878 | 15,89% | US$ 34,90M | 2026-01-13 |
| FMR LLC | Institution | 6.047.198 | 10,30% | US$ 22,62M | 2026-03-31 |
| BVF Partners L.P. | Institution | 5.842.000 | 9,95% | US$ 21,85M | 2026-03-31 |
| Deerfield Partners, LP | Institution | 5.139.523 | 8,75% | US$ 19,22M | 2026-03-31 |
| Deerfield Management Company, L.P. | Institution | 4.394.367 | 7,48% | US$ 16,43M | 2026-03-31 |
| Eli Lilly and Company | Institution | 4.000.000 | 6,81% | US$ 14,96M | 2026-04-20 |
| Dr. Cigall Kadoch | Insider | 3.624.379 | 6,17% | US$ 13,56M | 2026-04-20 |
| Biotechnology Value Fund L.P. | Institution | 3.139.797 | 5,35% | US$ 11,74M | 2026-03-31 |
| Raymond James Financial, Inc. | Institution | 2.602.382 | 4,43% | US$ 9,73M | 2026-03-31 |
| BlackRock, Inc. | Institution | 2.364.866 | 4,03% | US$ 8,84M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 2.218.382 | 3,78% | US$ 8,30M | 2026-03-31 |
| The Klarman Family Foundation | Institution | 2.139.639 | 3,64% | US$ 8,00M | 2024-09-30 |
| Flagship Pioneering Special Opportunities Fund II, L.P. | Institution | 1.851.801 | 3,15% | US$ 6,93M | 2026-01-13 |
| Euclidean Capital LLC | Institution | 1.573.761 | 2,68% | US$ 5,89M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1.495.089 | 2,55% | US$ 5,59M | 2026-03-31 |
| Flagship Ventures Opportunities Fund I, L.P. | Institution | 1.491.441 | 2,54% | US$ 5,58M | 2026-01-13 |
| Geode Capital Management, LLC | Institution | 848.172 | 1,44% | US$ 3,17M | 2026-03-31 |
| Artal Group S.A. | Institution | 720.720 | 1,23% | US$ 2,70M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 679.787 | 1,16% | US$ 2,54M | 2026-03-31 |
| Mr. Adrian H. Gottschalk | Insider | 511.704 | 0,87% | US$ 1,91M | 2026-04-20 |
| Columbia Management Investment Advisers, LLC | Institution | 448.976 | 0,76% | US$ 1,68M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 406.425 | 0,69% | US$ 1,52M | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 402.467 | 0,69% | US$ 1,51M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 313.765 | 0,53% | US$ 1,17M | 2026-03-31 |
| Jacobs Levy Equity Management Inc | Institution | 303.757 | 0,52% | US$ 1,14M | 2026-03-31 |
| Birchview Capital, LP | Institution | 281.730 | 0,48% | US$ 1,05M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 275.875 | 0,47% | US$ 1,03M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 255.931 | 0,44% | US$ 957,18k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 240.586 | 0,41% | US$ 899,79k | 2026-03-31 |
| Citadel Advisors LLC | Institution | 200.013 | 0,34% | US$ 748,05k | 2026-03-31 |
| Woodline Partners LP | Institution | 180.333 | 0,31% | US$ 674,45k | 2026-03-31 |
| Dr. Steven Bellon | Insider | 151.957 | 0,26% | US$ 568,32k | 2026-04-20 |
| Sio Capital Management, LLC | Institution | 122.889 | 0,21% | US$ 459,60k | 2026-03-31 |
| PanAgora Asset Management, Inc. | Institution | 115.063 | 0,20% | US$ 430,34k | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 111.859 | 0,19% | US$ 418,35k | 2026-03-31 |
| SCS Capital Management LLC | Institution | 106.980 | 0,18% | US$ 400,11k | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
